Impact News +++ Micron Isn't Nvidia. It's Time to Take Your Foot Off the Gas with MU Stock. (Barchart) +++ MICRON Aktie +3,06%

EMBECTA Aktie

>EMBECTA Aktienkurs

2.883 EUR +0.7% (TradegateBSX)

Ask: 2.903 EUR / 4200 Stück

Bid: 2.867 EUR / 4200 Stück

Tagesumsatz: 1599 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

EMBECTA Aktie über LYNX handeln

Intraday

1 Jahr

>EMBECTA Performance

1 Woche: +3,1%

1 Monat: -61,6%

3 Monate: -66,5%

6 Monate: -73,6%

1 Jahr: -68,7%

laufendes Jahr: -71,5%

>EMBECTA Aktie

Name:

EMBECTA CORP. DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US29082K1051 / A3DGNE

Symbol/ Ticker:

JX7 (Frankfurt) / EMBC (NASDAQ)

Kürzel:

FRA:JX7, ETR:JX7, JX7:GR, NASDAQ:EMBC

Index:

Webseite:

https://www.embecta.com/

Profil:

Embecta Corporation is a dynamic player in the healthcare industry, primarily focused on producing advanced medical devices. Its chief function is to innovate and manufacture devices related to diabetes care, addressing both individual and clinical n..
>Volltext..

Marktkapitalisierung:

167.5 Mio. EUR

Unternehmenswert:

1185.78 Mio. EUR

Umsatz:

894.61 Mio. EUR

EBITDA:

312.1 Mio. EUR

Nettogewinn:

96.03 Mio. EUR

Gewinn je Aktie:

1.64 EUR

Schulden:

1177.79 Mio. EUR

Liquide Mittel:

165.96 Mio. EUR

Operativer Cashflow:

Bargeldquote:

0.78

Umsatzwachstum:

-9.57%

Gewinnwachstum:

98.45%

Dividende je Aktie:

0.38 EUR

Dividendenrendite:

18.24%

Dividendenschätzung:

14.21%

Div. Historie:

27.02.26 - 0.12693€
05.12.25 - 0.128805€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

EMBECTA

Letzte Datenerhebung:

30.05.26

>EMBECTA Kennzahlen

Aktien/ Unternehmen:

Aktien: 59.33 Mio. St.

Frei handelbar: 92.19%

Leerverk. Aktien: 12.03%

Rückkaufquote: -

Mitarbeiter: 1850

Umsatz/Mitarb.: 0.5 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: 20.35%

Bewertung:

KGV: 1.73

KGV lG: 2.08

KUV: 0.19

KBV: -

PEG-Ratio: 0.02

EV/EBITDA: 3.8

Rentabilität:

Bruttomarge: 62.52%

Gewinnmarge: 10.73%

Operative Marge: 29.78%

Managementeffizenz:

Gesamtkaprendite: 10.41%

Eigenkaprendite: -

>EMBECTA Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Stoffwechselerkrankungen (Diabetes/ Adipositas)

>EMBECTA Chart & Kurs - NASDAQ

>EMBECTA News

20.05.26 - 15:01	Embecta Corp. (EMBC) Securities Fraud Investigation - Levi & Korsinsky (PR Newswire)
	Embecta's Q2 FY2026 revenue and EPS fell short of both company guidance and Wall Street consensus -- shares dropped more than 25% in a single session. NEW YORK, May 20, 2026 /PRNewswire/ -- Investors who held Embecta Corp. (NASDAQ: EMBC) shares lost more than 25% of their value when the......

15.05.26 - 15:03	embecta Completes Acquisition of Owen Mumford Holdings Limited (GlobeNewswire EN)
	PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced transaction to acquire Owen Mumford Holdings Limited (“Owen Mumford”), a privately held, UK-based innovator and manufacturer of medical devices and drug delivery technologies....

13.05.26 - 15:01	EMBC Investor Alert: Levi & Korsinsky Investigates Embecta Corp. (EMBC) for Potential Securities Fraud (PR Newswire)
	Embecta guided investors toward a $1.071-$1.093 billion revenue outlook for FY2026 while internal indicators reportedly already signaled the need for a cut -- shares later fell more than 25%. NEW YORK, May 13, 2026 /PRNewswire/ -- Shareholders who purchased Embecta Corp. (NASDAQ: EMBC)......

13.05.26 - 00:01	Schwache Nachfrage und Marktanteilsverluste: S&P stuft Embecta herab (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

08.05.26 - 15:03	embecta to Participate at the 2026 BofA Securities Global Health Care Conference (GlobeNewswire EN)
	PARSIPPANY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the 2026 BofA Securities Global Health Care Conference in Las Vegas on Wednesday, May 13, 2026 at 3:00 p.m. PT / 6:00 p.m. ET....

06.05.26 - 02:48	Why Embecta Stock Plummeted Today (Fool)
	Embecta's most recent quarterly report didn't give investors much to be exicited about....

05.05.26 - 22:13	Embecta (EMBC) Q2 2026 Earnings Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

05.05.26 - 15:21	Embecta slashes quarterly dividend from $0.15 to $0.01 a share (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

05.05.26 - 15:06	Embecta verfehlt Gewinnprognose für Q2 2026 deutlich – Aktie stürzt ab (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

05.05.26 - 12:45	Embecta misses top-line and bottom-line estimates; lowers FY26 outlook (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

05.05.26 - 12:33	Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results (GlobeNewswire EN)
	PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported second quarter fiscal 2026 financial results....

05.05.26 - 12:33	embecta Announces Quarterly Cash Dividend (GlobeNewswire EN)
	PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.01 for each issued and outstanding share of the Company's common stock. The dividend is payable on June 15, 2026 to stockholders of record at the close of business on May 28, 2026.About embecta...

21.04.26 - 23:03

embecta to Report Fiscal Second Quarter Financial Results (GlobeNewswire EN)

PARSIPPANY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal second quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Tuesday, May 5, 2026....

23.03.26 - 18:45	Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio (Zacks)
	EMBC to acquire Owen Mumford for up to $199.4M, aiming to expand beyond diabetes into high-value drug delivery and boost long-term growth....

19.03.26 - 11:48	Embecta to buy Owen Mumford for up to £150M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

19.03.26 - 11:33

embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited (GlobeNewswire EN)

Acquisition will position embecta to participate in the rapidly expanding market for drug-delivery devices supporting generic and branded therapies and accelerate transformation into a broad‑based medical supplies company Acquisition will position embecta to participate in the rapidly expanding market for drug-delivery devices supporting generic and branded therapies and accelerate transformation into a broad‑based medical supplies company...

26.02.26 - 00:03	XFRA: DIVIDEND/INTEREST INFORMATION - 27.02.2026 - US29082K1051 (XETRA)
	Das Instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 26.02.2026 und ex Dividende/Zinsen am 27.02.2026 The instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY has its pre-dividend/interest day on 26.02.2026 and its ex-dividend/interest day on 27.02.2026...

11.02.26 - 22:12	embecta names new Chairman of the Board and Lead Independent Director (GlobeNewswire EN)
	embecta names new Chairman of the Board and Lead Independent Director...

05.02.26 - 21:48	Embecta outlines $1.71B–$1.93B revenue target for 2026 as GLP-1 partnerships gain traction (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

05.02.26 - 15:48	Embecta (EMBC) Q1 2026 Earnings Call Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Also denk bei allem, was dich in Kummer versetzt, daran, folgenden Leitsatz anzuwenden: Nicht nur ist das kein Unglück, sondern es tapfer zu tragen ist ein Glück. - Mark Aurel

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram